354 related articles for article (PubMed ID: 34802380)
41. Network-based Pharmacology and
Long X; Chen L; Yang J; Dong T; Cheng Q; Wang W; Zou Y; Su Y; Dai W; Chen B; Zhou X
Anticancer Agents Med Chem; 2023; 23(7):847-857. PubMed ID: 36305128
[TBL] [Abstract][Full Text] [Related]
42. Protective Effect of 20(R)-Ginsenoside Rg3 Against Cisplatin-Induced Renal Toxicity via PI3K/AKT and NF-[Formula: see text]B Signaling Pathways Based on the Premise of Ensuring Anticancer Effect.
Zhang JJ; Zhou YD; Liu YB; Wang JQ; Li KK; Gong XJ; Lin XH; Wang YP; Wang Z; Li W
Am J Chin Med; 2021; 49(7):1739-1756. PubMed ID: 34461812
[TBL] [Abstract][Full Text] [Related]
43. Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular docking.
Zhang L; Han L; Wang X; Wei Y; Zheng J; Zhao L; Tong X
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 33634308
[TBL] [Abstract][Full Text] [Related]
44. 7-Hydroxycoumarin protects against cisplatin-induced acute kidney injury by inhibiting necroptosis and promoting Sox9-mediated tubular epithelial cell proliferation.
Wu WF; Wang JN; Li Z; Wei B; Jin J; Gao L; Li HD; Li J; Chen HY; Meng XM
Phytomedicine; 2020 Apr; 69():153202. PubMed ID: 32169782
[TBL] [Abstract][Full Text] [Related]
45. Dual-Responsive Curcumin-Loaded Nanoparticles for the Treatment of Cisplatin-Induced Acute Kidney Injury.
Lan T; Guo H; Lu X; Geng K; Wu L; Luo Y; Zhu J; Shen X; Guo Q; Wu S
Biomacromolecules; 2022 Dec; 23(12):5253-5266. PubMed ID: 36382792
[TBL] [Abstract][Full Text] [Related]
46. Study on the Mechanism of Prunella Vulgaris L on Diabetes Mellitus Complicated with Hypertension Based on Network Pharmacology and Molecular Docking Analyses.
Jiao X; Liu H; Lu Q; Wang Y; Zhao Y; Liu X; Liu F; Zuo Y; Wang W; Li Y
J Diabetes Res; 2021; 2021():9949302. PubMed ID: 34692849
[TBL] [Abstract][Full Text] [Related]
47. Rutaecarpine derivative Cpd-6c alleviates acute kidney injury by targeting PDE4B, a key enzyme mediating inflammation in cisplatin nephropathy.
Liu XQ; Jin J; Li Z; Jiang L; Dong YH; Cai YT; Wu MF; Wang JN; Ma TT; Wen JG; Liu MM; Li J; Wu YG; Meng XM
Biochem Pharmacol; 2020 Oct; 180():114132. PubMed ID: 32622666
[TBL] [Abstract][Full Text] [Related]
48. Prediction of the potential mechanism of compound gingerol against liver cancer based on network pharmacology and experimental verification.
Su M; Wang X; Cao G; Sun L; Ho RJY; Han Y; Hong Y; Wu D
J Pharm Pharmacol; 2022 Jun; 74(6):869-886. PubMed ID: 35429380
[TBL] [Abstract][Full Text] [Related]
49. Network Pharmacology-Based and Molecular Docking-Based Analysis of Suanzaoren Decoction for the Treatment of Parkinson's Disease with Sleep Disorder.
Liu YY; Yu LH; Zhang J; Xie DJ; Zhang XX; Yu JM
Biomed Res Int; 2021; 2021():1752570. PubMed ID: 34660782
[TBL] [Abstract][Full Text] [Related]
50. Formononetin protects against ox-LDL-induced endothelial dysfunction by activating PPAR-γ signaling based on network pharmacology and experimental validation.
Zhang B; Hao Z; Zhou W; Zhang S; Sun M; Li H; Hou N; Jing C; Zhao M
Bioengineered; 2021 Dec; 12(1):4887-4898. PubMed ID: 34369277
[TBL] [Abstract][Full Text] [Related]
51. Potential mechanisms of osthole against bladder cancer cells based on network pharmacology, molecular docking, and experimental validation.
Jiang Y; Zhang M; Wang L; Zhang L; Ma M; Jing M; Li J; Song R; Zhang Y; Yang Z; Zhang Y; Pu Y; Qu X; Fan J
BMC Complement Med Ther; 2023 Apr; 23(1):122. PubMed ID: 37069622
[TBL] [Abstract][Full Text] [Related]
52. Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID-19.
Xia QD; Xun Y; Lu JL; Lu YC; Yang YY; Zhou P; Hu J; Li C; Wang SG
Cell Prolif; 2020 Dec; 53(12):e12949. PubMed ID: 33140889
[TBL] [Abstract][Full Text] [Related]
53. Mitochondria targeted peptide SS-31 prevent on cisplatin-induced acute kidney injury via regulating mitochondrial ROS-NLRP3 pathway.
Yang SK; Han YC; He JR; Yang M; Zhang W; Zhan M; Li AM; Li L; Na-Song ; Liu YT; Wu XQ; Zhang Q; Wang JW; Zhang H
Biomed Pharmacother; 2020 Oct; 130():110521. PubMed ID: 32717631
[TBL] [Abstract][Full Text] [Related]
54. Network pharmacology-based strategy to investigate pharmacological mechanisms of Tinospora sinensis for treatment of Alzheimer's disease.
Zhou F; He K; Guan Y; Yang X; Chen Y; Sun M; Qiu X; Yan F; Huang H; Yao L; Liu B; Huang L
J Ethnopharmacol; 2020 Sep; 259():112940. PubMed ID: 32389853
[TBL] [Abstract][Full Text] [Related]
55. Upregulation of FABP7 inhibits acute kidney injury-induced TCMK-1 cell apoptosis via activating the PPAR gamma signalling pathway.
Xu D; Shen L; Zhou L; Sha W; Yang J; Lu G
Mol Omics; 2020 Dec; 16(6):533-542. PubMed ID: 33315023
[TBL] [Abstract][Full Text] [Related]
56. Thymoquinone and curcumin combination protects cisplatin-induced kidney injury, nephrotoxicity by attenuating NFκB, KIM-1 and ameliorating Nrf2/HO-1 signalling.
Al Fayi M; Otifi H; Alshyarba M; Dera AA; Rajagopalan P
J Drug Target; 2020 Nov; 28(9):913-922. PubMed ID: 31983246
[TBL] [Abstract][Full Text] [Related]
57. Assessing the recovery from prerenal and renal acute kidney injury after treatment with single herbal medicine via activity of the biomarkers HMGB1, NGAL and KIM-1 in kidney proximal tubular cells treated by cisplatin with different doses and exposure times.
Oh SM; Park G; Lee SH; Seo CS; Shin HK; Oh DS
BMC Complement Altern Med; 2017 Dec; 17(1):544. PubMed ID: 29258482
[TBL] [Abstract][Full Text] [Related]
58. Madecassoside alleviates acute kidney injury by regulating JNK-mediated oxidative stress and programmed cell death.
Shan RR; Yu JT; Zhang SF; Xie MM; Hou R; Xie CY; Dong ZH; Yang Q; Hu XW; Dong YH; Zhang Y; Luo XF; Cui ZY; Liu XY; Xie YC; Wen JG; Liu MM; Jin J; Chen Q; Meng XM
Phytomedicine; 2024 Jan; 123():155252. PubMed ID: 38056145
[TBL] [Abstract][Full Text] [Related]
59. A network pharmacology approach to identify the mechanisms and molecular targets of curcumin against Alzheimer disease.
Wu X; Zheng X; Tang H; Zhao L; He C; Zou Y; Song X; Li L; Yin Z; Ye G
Medicine (Baltimore); 2022 Aug; 101(34):e30194. PubMed ID: 36042609
[TBL] [Abstract][Full Text] [Related]
60. miR-132-3p promotes the cisplatin-induced apoptosis and inflammatory response of renal tubular epithelial cells by targeting SIRT1 via the NF-κB pathway.
Han S; Lin F; Ruan Y; Zhao S; Yuan R; Ning J; Jiang K; Xie J; Li H; Li C; Rao T; Yu W; Xia Y; Zhou X; Cheng F
Int Immunopharmacol; 2021 Oct; 99():108022. PubMed ID: 34339961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
